TScan Therapeutics Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
TScan Therapeutics Inc
CIK #0001783328
EDGAR Form CIK 2011 - 2026
10-K [0001783328]
10-Q [0001783328]
3 [0001783328]
4 [0001783328]
8-K [0001783328]
D [0001783328]
SC 13D [0001783328]
SC 13G [0001783328]
Form 13D/13G Filer Form 13D/13G Subject Filed
BlackRock Inc TScan Therapeutics Inc [2024-11-08]
BlackRock Inc TScan Therapeutics Inc [2024-10-21]
Cormorant Asset Management LP TScan Therapeutics Inc [2024-04-29]
Adage Capital Partners GP LLC TScan Therapeutics Inc [2023-06-12]
Biotechnology Value Fund L P TScan Therapeutics Inc [2023-06-05]
EcoR1 Capital LLC TScan Therapeutics Inc [2023-06-05]
Lynx1 Capital Management LP TScan Therapeutics Inc [2023-06-02]
K2 Healthventures Equity Trust LLC TScan Therapeutics Inc [2022-09-30]
Deer IX & Co Ltd TScan Therapeutics Inc [2022-02-14]
Hillhouse Investment Management Ltd TScan Therapeutics Inc [2022-02-14]
View All
Form 3/4/5 Subject 2011 - 2026
Klencke Barbara
TScan Therapeutics Inc
Nicholson Garry A
Gruia Gabriela
Dorton Katina
Woods Keith
Baker Brothers Life Sciences LP
Baker Bros Advisors GP LLC
667 LP
Baker Julian
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
TScan Therapeutics Inc TCRX
Stock Option (Right to Buy) · derivative
2026-01-20 Grant 350,000 $0.00
TScan Therapeutics Inc TCRX
Stock Option (Right to Buy) · derivative
2026-01-20 Grant 1,165,000 $0.00
TScan Therapeutics Inc TCRX
Stock Option (Right to Buy) · derivative
2026-01-20 Grant 100,000 $0.00
TScan Therapeutics Inc TCRX
Stock Option (Right to Buy) · derivative
2026-01-20 Grant 420,000 $0.00
TScan Therapeutics Inc TCRX
Stock Option (Right to Buy) · derivative
2026-01-20 Grant 350,000 $0.00
TScan Therapeutics Inc TCRX
Common Stock
2025-12-23 Buy 6,232 $0.90 5,609
TScan Therapeutics Inc TCRX
Common Stock
2025-12-22 Buy 75,500 $0.90 67,950
TScan Therapeutics Inc TCRX
"Common stock, $0.0001 par value per share (""Common Stock"")"
2025-12-19 Buy 80,069 $0.90 72,062
TScan Therapeutics Inc TCRX
Non- Qualified Stock Option (right to buy) · derivative
2025-06-30 Grant 67,000 $0.00
TScan Therapeutics Inc TCRX
Non- Qualified Stock Option (right to buy) · derivative
2025-06-30 Grant 67,000 $0.00
TScan Therapeutics Inc TCRX
Stock Option (Right to Buy) · derivative
2025-06-30 Grant 67,000 $0.00
TScan Therapeutics Inc TCRX
Stock Option (Right to Buy) · derivative
2025-06-30 Grant 67,000 $0.00
TScan Therapeutics Inc TCRX
Stock Option (Right to Buy) · derivative
2025-06-30 Grant 67,000 $0.00
TScan Therapeutics Inc TCRX
Stock Option (Right to Buy) · derivative
2025-06-30 Grant 67,000 $0.00
TScan Therapeutics Inc TCRX
Stock Option (Right to Buy) · derivative
2025-06-30 Grant 67,000 $0.00
TScan Therapeutics Inc TCRX
Common Stock
2025-05-20 Buy 1,200,000 $1.20 1,440,000
TScan Therapeutics Inc TCRX
"Common stock, $0.0001 par value per share (""Common Stock"")"
2025-05-19 Buy 1,388,794 $1.20 1,666,553
TScan Therapeutics Inc TCRX
Stock Option (Right to Buy) · derivative
2025-01-03 Grant 270,000 $0.00
TScan Therapeutics Inc TCRX
Stock Option (Right to Buy) · derivative
2025-01-03 Grant 250,000 $0.00
TScan Therapeutics Inc TCRX
Stock Option (Right to Buy) · derivative
2025-01-03 Grant 800,000 $0.00
showing 20 of 135 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com